Arcadia Biosciences, Inc. Common Stock (NASDAQ: RKDA) last traded at $0.208, down 7.96% on the session. The quote above updates while this page is open; the figures below are drawn from Arcadia Biosciences, Inc. Common Stock’s own filings and are restated only when a new one is published.
Arcadia Biosciences, Inc. Common Stock trades on NASDAQ under the ticker RKDA. Its market capitalisation is $501,115.888.
Valuation measures for Arcadia Biosciences, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $501.1K |
|---|---|
| Enterprise value | $1.58M |
| Price / sales | 0.11 |
| Price / book | 0.79 |
| Beta | 0.79 |
Trailing-twelve-month figures tagged in Arcadia Biosciences, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $4.75M |
|---|---|
| Net income (TTM) | -$11.09M |
| EPS (TTM) | -$4.55 |
| Gross margin | 34.60% |
| Operating margin | -80.15% |
| Return on equity | -1752.29% |
| Cash | $4.18M |
Range and volume for RKDA over the past 52 weeks.
| 52-week high | $5.72 |
|---|---|
| 52-week low | $0.188 |
| Volume | 7.88M |
| Average volume | 1.06M |
| Previous close | $0.226 |
Invest a chosen dollar amount in Arcadia Biosciences, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell RKDA.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.